Genotyping and macrolide-resistant mutation of Bordetella pertussis in East and South-East Asia
•Molecular surveillance of macrolide-resistant Bordetella pertussis (MRBP) was performed in East and Southeast Asia.•MBRP was detected in Vietnam, Cambodia, Taiwan, and Japan.•Most MRBP had the same MT104 and MT195 genotypes as Chinese MRBP.•The first MRBP isolates from Taiwan belonged to the MT104...
Saved in:
Published in | Journal of Global Antimicrobial Resistance Vol. 31; pp. 263 - 269 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
01.12.2022
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •Molecular surveillance of macrolide-resistant Bordetella pertussis (MRBP) was performed in East and Southeast Asia.•MBRP was detected in Vietnam, Cambodia, Taiwan, and Japan.•Most MRBP had the same MT104 and MT195 genotypes as Chinese MRBP.•The first MRBP isolates from Taiwan belonged to the MT104 cluster of Chinese MRBP.
Macrolide-resistant Bordetella pertussis (MRBP) has been emerging and prevailing in mainland China since 2011. In this study, we aimed to investigate the genotype and macrolide resistance of circulating B. pertussis in East and Southeast Asia using genetic analyses.
A total of 302 DNA extracts from clinical specimens and isolates from 2010 to 2020 were analyzed: 145 from Vietnam, 76 from Cambodia, 48 from Taiwan, and 33 from Japan. Genotypes were determined by multilocus variable-number tandem-repeat analysis (MLVA). Macrolide-resistant A2047G mutation in B. pertussis 23S rRNA was investigated using the duplex Cycleave real-time polymerase chain reaction (PCR) assay. Whole-genome sequencing was performed on two MRBP isolates that were identified for the first time in Taiwan.
Overall, 286 DNA extracts (95%) generated a complete MLVA genotype and 283 DNA extracts (94%) yielded a complete result for the A2047G mutation analysis. The A2047G mutation was detected in 18 DNA extracts: fourteen from Vietnam, one from Cambodia, two from Taiwan, and one from Japan. Most of them (78%) showed the genotypes MT104 and MT195, which have previously been reported in Chinese MRBP isolates. Further, the Taiwanese MRBP isolates were classified into the MT104 clade of Chinese MRBP isolates.
After MRBP emerged and spread in mainland China, it may have spread to East and Southeast Asia in the 2010s. Continued surveillance targeting the A2047G mutation of MRBP is needed to prevent further spread of this emerging pathogen. |
---|---|
AbstractList | Highlights•Molecular surveillance of macrolide-resistant B. pertussis (MRBP) was performed in East and South-East Asia. •MRBP was detected in Vietnam, Cambodia, Taiwan, and Japan. •Most MRBP had the same MT104 and MT195 genotypes as Chinese MRBP. •The first MRBP isolates from Taiwan belonged to the MT104 cluster of Chinese MRBP. Macrolide-resistant Bordetella pertussis (MRBP) has been emerging and prevailing in mainland China since 2011. In this study, we aimed to investigate the genotype and macrolide resistance of circulating B. pertussis in East and Southeast Asia using genetic analyses. A total of 302 DNA extracts from clinical specimens and isolates from 2010 to 2020 were analyzed: 145 from Vietnam, 76 from Cambodia, 48 from Taiwan, and 33 from Japan. Genotypes were determined by multilocus variable-number tandem-repeat analysis (MLVA). Macrolide-resistant A2047G mutation in B. pertussis 23S rRNA was investigated using the duplex Cycleave real-time polymerase chain reaction (PCR) assay. Whole-genome sequencing was performed on two MRBP isolates that were identified for the first time in Taiwan. Overall, 286 DNA extracts (95%) generated a complete MLVA genotype and 283 DNA extracts (94%) yielded a complete result for the A2047G mutation analysis. The A2047G mutation was detected in 18 DNA extracts: fourteen from Vietnam, one from Cambodia, two from Taiwan, and one from Japan. Most of them (78%) showed the genotypes MT104 and MT195, which have previously been reported in Chinese MRBP isolates. Further, the Taiwanese MRBP isolates were classified into the MT104 clade of Chinese MRBP isolates. After MRBP emerged and spread in mainland China, it may have spread to East and Southeast Asia in the 2010s. Continued surveillance targeting the A2047G mutation of MRBP is needed to prevent further spread of this emerging pathogen. Objectives: Macrolide-resistant Bordetella pertussis (MRBP) has been emerging and prevailing in mainland China since 2011. In this study, we aimed to investigate the genotype and macrolide resistance of circulating B. pertussis in East and Southeast Asia using genetic analyses. Methods: A total of 302 DNA extracts from clinical specimens and isolates from 2010 to 2020 were analyzed: 145 from Vietnam, 76 from Cambodia, 48 from Taiwan, and 33 from Japan. Genotypes were determined by multilocus variable-number tandem-repeat analysis (MLVA). Macrolide-resistant A2047G mutation in B. pertussis 23S rRNA was investigated using the duplex Cycleave real-time polymerase chain reaction (PCR) assay. Whole-genome sequencing was performed on two MRBP isolates that were identified for the first time in Taiwan. Results: Overall, 286 DNA extracts (95%) generated a complete MLVA genotype and 283 DNA extracts (94%) yielded a complete result for the A2047G mutation analysis. The A2047G mutation was detected in 18 DNA extracts: fourteen from Vietnam, one from Cambodia, two from Taiwan, and one from Japan. Most of them (78%) showed the genotypes MT104 and MT195, which have previously been reported in Chinese MRBP isolates. Further, the Taiwanese MRBP isolates were classified into the MT104 clade of Chinese MRBP isolates. Conclusion: After MRBP emerged and spread in mainland China, it may have spread to East and Southeast Asia in the 2010s. Continued surveillance targeting the A2047G mutation of MRBP is needed to prevent further spread of this emerging pathogen. •Molecular surveillance of macrolide-resistant Bordetella pertussis (MRBP) was performed in East and Southeast Asia.•MBRP was detected in Vietnam, Cambodia, Taiwan, and Japan.•Most MRBP had the same MT104 and MT195 genotypes as Chinese MRBP.•The first MRBP isolates from Taiwan belonged to the MT104 cluster of Chinese MRBP. Macrolide-resistant Bordetella pertussis (MRBP) has been emerging and prevailing in mainland China since 2011. In this study, we aimed to investigate the genotype and macrolide resistance of circulating B. pertussis in East and Southeast Asia using genetic analyses. A total of 302 DNA extracts from clinical specimens and isolates from 2010 to 2020 were analyzed: 145 from Vietnam, 76 from Cambodia, 48 from Taiwan, and 33 from Japan. Genotypes were determined by multilocus variable-number tandem-repeat analysis (MLVA). Macrolide-resistant A2047G mutation in B. pertussis 23S rRNA was investigated using the duplex Cycleave real-time polymerase chain reaction (PCR) assay. Whole-genome sequencing was performed on two MRBP isolates that were identified for the first time in Taiwan. Overall, 286 DNA extracts (95%) generated a complete MLVA genotype and 283 DNA extracts (94%) yielded a complete result for the A2047G mutation analysis. The A2047G mutation was detected in 18 DNA extracts: fourteen from Vietnam, one from Cambodia, two from Taiwan, and one from Japan. Most of them (78%) showed the genotypes MT104 and MT195, which have previously been reported in Chinese MRBP isolates. Further, the Taiwanese MRBP isolates were classified into the MT104 clade of Chinese MRBP isolates. After MRBP emerged and spread in mainland China, it may have spread to East and Southeast Asia in the 2010s. Continued surveillance targeting the A2047G mutation of MRBP is needed to prevent further spread of this emerging pathogen. Macrolide-resistant Bordetella pertussis (MRBP) has been emerging and prevailing in mainland China since 2011. In this study, we aimed to investigate the genotype and macrolide resistance of circulating B. pertussis in East and Southeast Asia using genetic analyses.OBJECTIVESMacrolide-resistant Bordetella pertussis (MRBP) has been emerging and prevailing in mainland China since 2011. In this study, we aimed to investigate the genotype and macrolide resistance of circulating B. pertussis in East and Southeast Asia using genetic analyses.A total of 302 DNA extracts from clinical specimens and isolates from 2010 to 2020 were analyzed: 145 from Vietnam, 76 from Cambodia, 48 from Taiwan, and 33 from Japan. Genotypes were determined by multilocus variable-number tandem-repeat analysis (MLVA). Macrolide-resistant A2047G mutation in B. pertussis 23S rRNA was investigated using the duplex Cycleave real-time polymerase chain reaction (PCR) assay. Whole-genome sequencing was performed on two MRBP isolates that were identified for the first time in Taiwan.METHODSA total of 302 DNA extracts from clinical specimens and isolates from 2010 to 2020 were analyzed: 145 from Vietnam, 76 from Cambodia, 48 from Taiwan, and 33 from Japan. Genotypes were determined by multilocus variable-number tandem-repeat analysis (MLVA). Macrolide-resistant A2047G mutation in B. pertussis 23S rRNA was investigated using the duplex Cycleave real-time polymerase chain reaction (PCR) assay. Whole-genome sequencing was performed on two MRBP isolates that were identified for the first time in Taiwan.Overall, 286 DNA extracts (95%) generated a complete MLVA genotype and 283 DNA extracts (94%) yielded a complete result for the A2047G mutation analysis. The A2047G mutation was detected in 18 DNA extracts: fourteen from Vietnam, one from Cambodia, two from Taiwan, and one from Japan. Most of them (78%) showed the genotypes MT104 and MT195, which have previously been reported in Chinese MRBP isolates. Further, the Taiwanese MRBP isolates were classified into the MT104 clade of Chinese MRBP isolates.RESULTSOverall, 286 DNA extracts (95%) generated a complete MLVA genotype and 283 DNA extracts (94%) yielded a complete result for the A2047G mutation analysis. The A2047G mutation was detected in 18 DNA extracts: fourteen from Vietnam, one from Cambodia, two from Taiwan, and one from Japan. Most of them (78%) showed the genotypes MT104 and MT195, which have previously been reported in Chinese MRBP isolates. Further, the Taiwanese MRBP isolates were classified into the MT104 clade of Chinese MRBP isolates.After MRBP emerged and spread in mainland China, it may have spread to East and Southeast Asia in the 2010s. Continued surveillance targeting the A2047G mutation of MRBP is needed to prevent further spread of this emerging pathogen.CONCLUSIONAfter MRBP emerged and spread in mainland China, it may have spread to East and Southeast Asia in the 2010s. Continued surveillance targeting the A2047G mutation of MRBP is needed to prevent further spread of this emerging pathogen. |
Author | Chiang, Chuen‑Sheue Huong, Do Thu Samnang, Chham Koide, Kentaro Saitoh, Akihiko Nakajima, Noriko Vichit, Ork Kamachi, Kazunari Vutthikol, Yong Otsuka, Nao Thuy, Phung Thi Bich Takayama, Ikuyo Nga, Do Thi Thuy Yao, ShuMan Sovannara, Siphan Dien, Tran Minh Ainai, Akira |
Author_xml | – sequence: 1 givenname: Kentaro orcidid: 0000-0002-9840-3689 surname: Koide fullname: Koide, Kentaro organization: Department of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 2 givenname: ShuMan surname: Yao fullname: Yao, ShuMan organization: Centre for Diagnostics and Vaccine Development, Centres for Disease Control, Taipei, Taiwan – sequence: 3 givenname: Chuen‑Sheue surname: Chiang fullname: Chiang, Chuen‑Sheue organization: Centre for Diagnostics and Vaccine Development, Centres for Disease Control, Taipei, Taiwan – sequence: 4 givenname: Phung Thi Bich surname: Thuy fullname: Thuy, Phung Thi Bich organization: Department of Molecular Biology for Infectious Disease, Vietnam National Children's Hospital, Hanoi, Vietnam – sequence: 5 givenname: Do Thi Thuy surname: Nga fullname: Nga, Do Thi Thuy organization: Division of General Internal Medicine, Centre for Tropical Diseases, Vietnam National Children's Hospital, Hanoi, Vietnam – sequence: 6 givenname: Do Thu orcidid: 0000-0002-5332-3044 surname: Huong fullname: Huong, Do Thu organization: Division of General Internal Medicine, Centre for Tropical Diseases, Vietnam National Children's Hospital, Hanoi, Vietnam – sequence: 7 givenname: Tran Minh surname: Dien fullname: Dien, Tran Minh organization: Surgical Intensive Care Unit, Vietnam National Children's Hospital, Hanoi, Vietnam – sequence: 8 givenname: Ork surname: Vichit fullname: Vichit, Ork organization: National Immunization Program, Ministry of Health, Cambodia – sequence: 9 givenname: Yong surname: Vutthikol fullname: Vutthikol, Yong organization: National Immunization Program, Ministry of Health, Cambodia – sequence: 10 givenname: Siphan surname: Sovannara fullname: Sovannara, Siphan organization: National Immunization Program, Ministry of Health, Cambodia – sequence: 11 givenname: Chham surname: Samnang fullname: Samnang, Chham organization: Vaccine-Preventable Diseases and Immunization, World Health Organization, Cambodia – sequence: 12 givenname: Ikuyo orcidid: 0000-0001-7594-8275 surname: Takayama fullname: Takayama, Ikuyo organization: Research Centre for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 13 givenname: Akira surname: Ainai fullname: Ainai, Akira organization: Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 14 givenname: Noriko surname: Nakajima fullname: Nakajima, Noriko organization: Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 15 givenname: Nao surname: Otsuka fullname: Otsuka, Nao organization: Department of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 16 givenname: Kazunari orcidid: 0000-0001-5259-1744 surname: Kamachi fullname: Kamachi, Kazunari email: kamachi@nih.go.jp organization: Department of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 17 givenname: Akihiko surname: Saitoh fullname: Saitoh, Akihiko organization: Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36270447$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uk1v1DAQtVARbZf-AQ4oRy5Z_JHYCQekUpW2UiUOhbM1SSaLQ2IvtoO0_x5n0_aARE_2jOa9mXlvzsmJdRYJecfollEmPw7bYQd-yynnKbGlVL0iZ5wzkSumxMnzX5an5CIE09CSKiFkQd-QUyG5okWhzoi-QeviYW_sLgPbZRO03o2mw9xjMCGCjdk0R4jG2cz12RfnO4w4jpDt0cc5MYfM2OwaQjwSPLg5_syP4WUw8Ja87mEMePH4bsiPr9ffr27z-283d1eX93lbVmXMkbIeK0axqLFcRoNWogJBZQq7CpTESohe1CytwIVo-47VgtUMOopVV4gNuVt5OweD3nszgT9oB0YfE87vNPho2hG1RGxKKWjDqCyaum9UV_O6ANbLQomqSVwfVq69d79nDFFPJrTLzhbdHDRXXMmCqTTMhrx_LJ2bCbvnxk8Cp4JqLUiyhuCx161Z1YwezKgZ1YudetCLnXqxc8klOxOU_wN9Yn8R9HkFYRL7j0Gv29FY08L4Cw8YBjd7m3zQTAeuqX5YrmQ5Es4p5aJaCD79nyCJaV7q_hcXtcts |
CitedBy_id | crossref_primary_10_3947_ic_2024_0117 crossref_primary_10_1128_cmr_00164_22 crossref_primary_10_1128_iai_00271_24 crossref_primary_10_1371_journal_pone_0298147 crossref_primary_10_3201_eid3001_221588 crossref_primary_10_1016_j_jiph_2024_102610 crossref_primary_10_3389_fcimb_2023_1181633 crossref_primary_10_1128_jcm_01178_24 crossref_primary_10_1016_j_procbio_2024_06_033 crossref_primary_10_3390_antibiotics11111570 |
Cites_doi | 10.1097/01.inf.0000160914.59160.41 10.7883/yoken.JJID.2019.421 10.1097/INF.0000000000001814 10.1080/22221751.2019.1587315 10.3201/eid2512.181836 10.1128/JCM.01499-15 10.1007/s10096-016-2655-3 10.1111/1469-0691.12161 10.1099/jmm.0.049585-0 10.1097/INF.0000000000002911 10.1093/molbev/msy096 10.1371/journal.pone.0031985 10.1128/AAC.01081-13 10.1016/j.ijid.2017.07.015 10.1186/2050-6511-15-6 10.1111/1469-0691.12671 10.1016/j.ijid.2015.04.001 10.1080/14760584.2020.1831916 10.3201/eid2610.201035 10.1097/INF.0000000000002160 10.1099/jmm.0.2008/002857-0 10.3201/eid2304.161575 10.1371/journal.pone.0104984 10.1542/peds.2014-1729 |
ContentType | Journal Article |
Copyright | 2022 Copyright © 2022. Published by Elsevier Ltd. |
Copyright_xml | – notice: 2022 – notice: Copyright © 2022. Published by Elsevier Ltd. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 DOA |
DOI | 10.1016/j.jgar.2022.10.007 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2213-7173 |
EndPage | 269 |
ExternalDocumentID | oai_doaj_org_article_6eeb5630b1064b9fb7d9294a1f64738b 36270447 10_1016_j_jgar_2022_10_007 1_s2_0_S2213716522002387 S2213716522002387 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Asia, Southeastern Asia, Eastern |
GeographicLocations_xml | – name: Asia, Eastern – name: Asia, Southeastern |
GrantInformation_xml | – fundername: World Health Organization grantid: 001 |
GroupedDBID | ALMA_UNASSIGNED_HOLDINGS M~E --M .1- .FO .~1 0R~ 1~. 4.4 457 4G. 53G 7-5 8P~ AAAJQ AABSN AACTN AAEDT AAEDW AAHOK AAIKJ AAKOC AALRI AAOAW AAQFI AAXKI AAXUO ABJNI ABMAC ABMZM ABXDB ACDAQ ACGFS ACRLP ADBBV ADEZE ADVLN AEBSH AEIPS AEKER AENEX AFCTW AFJKZ AFKWA AFRHN AFTJW AFXIZ AGEKW AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK AMFUW AMRAJ ANKPU ANZVX AXJTR BKOJK BLXMC BNPGV CJTIS COPKO EBS EFJIC EJD FDB FEDTE FIRID FNPLU FYGXN GBLVA GROUPED_DOAJ HVGLF HZ~ KOM LUGTX M41 MO0 NCXOZ O-L O9- OAUVE OK1 P-8 P-9 PC. Q38 RIG ROL SDF SPCBC SSH SSI SSZ T5K Z5R ~G- AATTM AAYWO AAYXX ACIEU ACVFH ADCNI AEUPX AFPUW AGCQF AGRNS AIGII AIIUN AKBMS AKYEP APXCP CITATION CGR CUY CVF ECM EFKBS EIF NPM 7X8 |
ID | FETCH-LOGICAL-c585t-e01fe810e49e57044ac6e7a306e57d8a76e833f391336233cfd193191ad0e8d43 |
IEDL.DBID | DOA |
ISSN | 2213-7165 2213-7173 |
IngestDate | Wed Aug 27 01:21:11 EDT 2025 Fri Jul 11 06:20:54 EDT 2025 Mon Jul 21 06:08:04 EDT 2025 Thu Apr 24 23:00:07 EDT 2025 Tue Jul 01 03:34:47 EDT 2025 Tue Feb 25 20:01:07 EST 2025 Tue Aug 26 19:10:40 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Multilocus variable-number tandem-repeat analysis 23S rRNA Bordetella pertussis East and Southeast Asia Macrolide-resistant A2047G mutation Whole-genome sequencing East and South-East Asia macrolide-resistant A2047G mutation multilocus variable-number tandem-repeat analysis whole-genome sequencing |
Language | English |
License | This is an open access article under the CC BY IGO license. Copyright © 2022. Published by Elsevier Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c585t-e01fe810e49e57044ac6e7a306e57d8a76e833f391336233cfd193191ad0e8d43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-9840-3689 0000-0001-7594-8275 0000-0002-5332-3044 0000-0001-5259-1744 |
OpenAccessLink | https://doaj.org/article/6eeb5630b1064b9fb7d9294a1f64738b |
PMID | 36270447 |
PQID | 2727641791 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_6eeb5630b1064b9fb7d9294a1f64738b proquest_miscellaneous_2727641791 pubmed_primary_36270447 crossref_citationtrail_10_1016_j_jgar_2022_10_007 crossref_primary_10_1016_j_jgar_2022_10_007 elsevier_clinicalkeyesjournals_1_s2_0_S2213716522002387 elsevier_clinicalkey_doi_10_1016_j_jgar_2022_10_007 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-12-01 |
PublicationDateYYYYMMDD | 2022-12-01 |
PublicationDate_xml | – month: 12 year: 2022 text: 2022-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Journal of Global Antimicrobial Resistance |
PublicationTitleAlternate | J Glob Antimicrob Resist |
PublicationYear | 2022 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Yao, Deng, Ma, Dai, Chen, Zhou (bib0014) 2020; 19 Galit, Otsuka, Furuse, Almonia, Sombrero, Capeding (bib0016) 2015; 35 Yamaguchi, Kawasaki, Katsukawa, Kawahara, Kawatsu (bib0009) 2020; 73 Fu, Wang, Tian, Kang, Zeng (bib0006) 2019; 38 Yang, Yao, Ma, Shi, Yuan, Yang (bib0005) 2015; 10 Yao, Liaw, Chen, Yen, Chen, Mu (bib0025) 2008; 57 Zhang, Li, Wang, Xin, He (bib0007) 2013; 19 Zhang, Zhang, Wang, Wei, Li (bib0004) 2022; 50 Liu, Wang, Zhang, Li, Luan, Li (bib0028) 2018; 37 Wang, Cui, Li, Hou, Liu, Xi (bib0011) 2014; 20 Wang, Han, Liu, Du, Liu, Ma (bib0019) 2015; 53 Feng, Chiu, Heininger, Hozbor, Tan, von Konig (bib0003) 2021; 8 Litt, Jauneikaite, Tchipeva, Harrison, Fry (bib0017) 2012; 61 Hiramatsu, Miyaji, Otsuka, Arakawa, Shibayama, Kamachi (bib0020) 2017; 23 Wang, Li, Hou, Liu, Liu, Yu (bib0010) 2013; 57 Moriuchi, Vichit, Vutthikol, Hossain, Samnang, Toda (bib0018) 2017; 62 Wendelboe, Van Rie, Salmaso, Englund (bib0001) 2005; 24 Kamachi, Duong, Dang, Hai, Do, Koide (bib0008) 2020; 26 McGirr, Fisman (bib0002) 2015; 135 Xu, Wang, Luan, Li, Liu, Peng (bib0013) 2019; 8 Li, Deng, Ma, Zhou, Meng, Yuan (bib0012) 2019; 25 Nga do, Chuc, Hoa, Hoa, Nguyen, Loan (bib0026) 2014; 15 Du, Wang, Liu, Luan, Zhang, Li (bib0015) 2016; 35 Kaas, Leekitcharoenphon, Aarestrup, Lund (bib0022) 2014; 9 Otsuka, Han, Toyoizumi-Ajisaka, Nakamura, Arakawa, Shibayama (bib0021) 2012; 7 Kumar, Stecher, Li, Knyaz, Tamura (bib0023) 2018; 35 Wu, Du, Li, Yuan, Meng, Fu (bib0024) 2022; 13 Mi, Hua, Fang, Liu, Xie, Lin (bib0027) 2021; 40 Litt (10.1016/j.jgar.2022.10.007_bib0017) 2012; 61 Wendelboe (10.1016/j.jgar.2022.10.007_bib0001) 2005; 24 Wang (10.1016/j.jgar.2022.10.007_bib0011) 2014; 20 Kumar (10.1016/j.jgar.2022.10.007_bib0023) 2018; 35 Kamachi (10.1016/j.jgar.2022.10.007_bib0008) 2020; 26 Wang (10.1016/j.jgar.2022.10.007_bib0019) 2015; 53 Yao (10.1016/j.jgar.2022.10.007_bib0025) 2008; 57 Nga do (10.1016/j.jgar.2022.10.007_bib0026) 2014; 15 Xu (10.1016/j.jgar.2022.10.007_bib0013) 2019; 8 Li (10.1016/j.jgar.2022.10.007_bib0012) 2019; 25 Wang (10.1016/j.jgar.2022.10.007_bib0010) 2013; 57 Fu (10.1016/j.jgar.2022.10.007_bib0006) 2019; 38 McGirr (10.1016/j.jgar.2022.10.007_bib0002) 2015; 135 Yao (10.1016/j.jgar.2022.10.007_bib0014) 2020; 19 Wu (10.1016/j.jgar.2022.10.007_bib0024) 2022; 13 Du (10.1016/j.jgar.2022.10.007_bib0015) 2016; 35 Moriuchi (10.1016/j.jgar.2022.10.007_bib0018) 2017; 62 Kaas (10.1016/j.jgar.2022.10.007_bib0022) 2014; 9 Yamaguchi (10.1016/j.jgar.2022.10.007_bib0009) 2020; 73 Otsuka (10.1016/j.jgar.2022.10.007_bib0021) 2012; 7 Liu (10.1016/j.jgar.2022.10.007_bib0028) 2018; 37 Hiramatsu (10.1016/j.jgar.2022.10.007_bib0020) 2017; 23 Mi (10.1016/j.jgar.2022.10.007_bib0027) 2021; 40 Zhang (10.1016/j.jgar.2022.10.007_bib0007) 2013; 19 Feng (10.1016/j.jgar.2022.10.007_bib0003) 2021; 8 Zhang (10.1016/j.jgar.2022.10.007_bib0004) 2022; 50 Yang (10.1016/j.jgar.2022.10.007_bib0005) 2015; 10 Galit (10.1016/j.jgar.2022.10.007_bib0016) 2015; 35 |
References_xml | – volume: 19 start-page: 1093 year: 2020 end-page: 1099 ident: bib0014 article-title: The epidemic of erythromycin-resistant publication-title: Expert Rev Vaccines – volume: 35 start-page: 1547 year: 2018 end-page: 1549 ident: bib0023 article-title: MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms publication-title: Mol Biol Evol – volume: 38 start-page: 370 year: 2019 end-page: 376 ident: bib0006 article-title: infection in infants and young children in Shanghai, China, 2016–2017: Clinical features, genotype variations of antigenic genes and macrolides resistance publication-title: Pediatr Infect Dis J – volume: 62 start-page: 56 year: 2017 end-page: 58 ident: bib0018 article-title: Molecular epidemiology of publication-title: Int J Infect Dis – volume: 7 start-page: e31985 year: 2012 ident: bib0021 article-title: Prevalence and genetic characterization of pertactin-deficient publication-title: PLoS One – volume: 15 start-page: 6 year: 2014 ident: bib0026 article-title: Antibiotic sales in rural and urban pharmacies in northern Vietnam: an observational study publication-title: BMC Pharmacol Toxicol – volume: 20 start-page: O825 year: 2014 end-page: O830 ident: bib0011 article-title: High prevalence of erythromycin-resistant publication-title: Clin Microbiol Infect – volume: 53 start-page: 3418 year: 2015 end-page: 3422 ident: bib0019 article-title: Direct detection of erythromycin-resistant publication-title: J Clin Microbiol – volume: 9 year: 2014 ident: bib0022 article-title: Solving the problem of comparing whole bacterial genomes across different sequencing platforms publication-title: PLoS One – volume: 24 start-page: S58 year: 2005 end-page: S61 ident: bib0001 article-title: Duration of immunity against pertussis after natural infection or vaccination publication-title: Pediatr Infect Dis J – volume: 10 year: 2015 ident: bib0005 article-title: Variation in publication-title: PLoS One – volume: 37 start-page: e145 year: 2018 end-page: e148 ident: bib0028 article-title: Pertussis outbreak in a primary school in China: infection and transmission of the macrolide-resistant publication-title: Pediatr Infect Dis J – volume: 57 start-page: 1577 year: 2008 end-page: 1580 ident: bib0025 article-title: Antimicrobial susceptibility testing of publication-title: J Med Microbiol – volume: 135 start-page: 331 year: 2015 end-page: 343 ident: bib0002 article-title: Duration of pertussis immunity after DTaP immunization: a meta-analysis publication-title: Pediatrics – volume: 50 year: 2022 ident: bib0004 article-title: Macrolide susceptibility and molecular characteristics of publication-title: J Int Med Res – volume: 57 start-page: 5193 year: 2013 end-page: 5194 ident: bib0010 article-title: Appearance of macrolide-resistant publication-title: Antimicrob Agents Chemother – volume: 8 year: 2021 ident: bib0003 article-title: Emerging macrolide resistance in publication-title: Lancet Reg Health West Pac – volume: 13 year: 2022 ident: bib0024 article-title: A cross-sectional study revealing the emergence of erythromycin-resistant publication-title: Front Microbiol – volume: 61 start-page: 1662 year: 2012 end-page: 1668 ident: bib0017 article-title: Direct molecular typing of publication-title: J Med Microbiol – volume: 19 start-page: E260 year: 2013 end-page: E262 ident: bib0007 article-title: High-resolution melting analysis for the detection of two erythromycin-resistant publication-title: Clin Microbiol Infect – volume: 8 start-page: 461 year: 2019 end-page: 470 ident: bib0013 article-title: Genomic epidemiology of erythromycin-resistant publication-title: Emerg Microbes Infect – volume: 35 start-page: 1211 year: 2016 end-page: 1214 ident: bib0015 article-title: Direct molecular typing of publication-title: Eur J Clin Microbiol Infect Dis – volume: 25 start-page: 2205 year: 2019 end-page: 2214 ident: bib0012 article-title: High prevalence of macrolide-resistant publication-title: Emerg Infect Dis – volume: 40 start-page: 87 year: 2021 end-page: 90 ident: bib0027 article-title: Effect of macrolides and beta-lactams on clearance of publication-title: Pediatr Infect Dis J – volume: 35 start-page: 24 year: 2015 end-page: 26 ident: bib0016 article-title: Molecular epidemiology of publication-title: Int J Infect Dis – volume: 23 start-page: 699 year: 2017 end-page: 701 ident: bib0020 article-title: Significant decrease in pertactin-deficient publication-title: Emerg Infect Dis – volume: 26 start-page: 2511 year: 2020 end-page: 2513 ident: bib0008 article-title: Macrolide-resistant publication-title: Emerg Infect Dis – volume: 73 start-page: 361 year: 2020 end-page: 362 ident: bib0009 article-title: The first report of macrolide-resistant publication-title: Jpn J Infect Dis – volume: 24 start-page: S58 year: 2005 ident: 10.1016/j.jgar.2022.10.007_bib0001 article-title: Duration of immunity against pertussis after natural infection or vaccination publication-title: Pediatr Infect Dis J doi: 10.1097/01.inf.0000160914.59160.41 – volume: 73 start-page: 361 year: 2020 ident: 10.1016/j.jgar.2022.10.007_bib0009 article-title: The first report of macrolide-resistant Bordetella pertussis isolation in Japan publication-title: Jpn J Infect Dis doi: 10.7883/yoken.JJID.2019.421 – volume: 8 year: 2021 ident: 10.1016/j.jgar.2022.10.007_bib0003 article-title: Emerging macrolide resistance in Bordetella pertussis in mainland China: findings and warning from the global pertussis initiative publication-title: Lancet Reg Health West Pac – volume: 37 start-page: e145 year: 2018 ident: 10.1016/j.jgar.2022.10.007_bib0028 article-title: Pertussis outbreak in a primary school in China: infection and transmission of the macrolide-resistant Bordetella pertussis publication-title: Pediatr Infect Dis J doi: 10.1097/INF.0000000000001814 – volume: 8 start-page: 461 year: 2019 ident: 10.1016/j.jgar.2022.10.007_bib0013 article-title: Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China publication-title: Emerg Microbes Infect doi: 10.1080/22221751.2019.1587315 – volume: 25 start-page: 2205 year: 2019 ident: 10.1016/j.jgar.2022.10.007_bib0012 article-title: High prevalence of macrolide-resistant Bordetella pertussis and ptxP1 genotype, mainland China, 2014–2016 publication-title: Emerg Infect Dis doi: 10.3201/eid2512.181836 – volume: 53 start-page: 3418 year: 2015 ident: 10.1016/j.jgar.2022.10.007_bib0019 article-title: Direct detection of erythromycin-resistant Bordetella pertussis in clinical specimens by PCR publication-title: J Clin Microbiol doi: 10.1128/JCM.01499-15 – volume: 35 start-page: 1211 year: 2016 ident: 10.1016/j.jgar.2022.10.007_bib0015 article-title: Direct molecular typing of Bordetella pertussis from nasopharyngeal specimens in China in 2012–2013 publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-016-2655-3 – volume: 19 start-page: E260 year: 2013 ident: 10.1016/j.jgar.2022.10.007_bib0007 article-title: High-resolution melting analysis for the detection of two erythromycin-resistant Bordetella pertussis strains carried by healthy schoolchildren in China publication-title: Clin Microbiol Infect doi: 10.1111/1469-0691.12161 – volume: 61 start-page: 1662 year: 2012 ident: 10.1016/j.jgar.2022.10.007_bib0017 article-title: Direct molecular typing of Bordetella pertussis from clinical specimens submitted for diagnostic quantitative (real-time) PCR publication-title: J Med Microbiol doi: 10.1099/jmm.0.049585-0 – volume: 40 start-page: 87 year: 2021 ident: 10.1016/j.jgar.2022.10.007_bib0027 article-title: Effect of macrolides and beta-lactams on clearance of Bordetella pertussis in the nasopharynx in children with whooping cough publication-title: Pediatr Infect Dis J doi: 10.1097/INF.0000000000002911 – volume: 35 start-page: 1547 year: 2018 ident: 10.1016/j.jgar.2022.10.007_bib0023 article-title: MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms publication-title: Mol Biol Evol doi: 10.1093/molbev/msy096 – volume: 7 start-page: e31985 year: 2012 ident: 10.1016/j.jgar.2022.10.007_bib0021 article-title: Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan publication-title: PLoS One doi: 10.1371/journal.pone.0031985 – volume: 57 start-page: 5193 year: 2013 ident: 10.1016/j.jgar.2022.10.007_bib0010 article-title: Appearance of macrolide-resistant Bordetella pertussis strains in China publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01081-13 – volume: 62 start-page: 56 year: 2017 ident: 10.1016/j.jgar.2022.10.007_bib0018 article-title: Molecular epidemiology of Bordetella pertussis in Cambodia determined by direct genotyping of clinical specimens publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2017.07.015 – volume: 13 year: 2022 ident: 10.1016/j.jgar.2022.10.007_bib0024 article-title: A cross-sectional study revealing the emergence of erythromycin-resistant Bordetella pertussis carrying ptxP3 alleles in China publication-title: Front Microbiol – volume: 15 start-page: 6 year: 2014 ident: 10.1016/j.jgar.2022.10.007_bib0026 article-title: Antibiotic sales in rural and urban pharmacies in northern Vietnam: an observational study publication-title: BMC Pharmacol Toxicol doi: 10.1186/2050-6511-15-6 – volume: 50 year: 2022 ident: 10.1016/j.jgar.2022.10.007_bib0004 article-title: Macrolide susceptibility and molecular characteristics of Bordetella pertussis publication-title: J Int Med Res – volume: 20 start-page: O825 year: 2014 ident: 10.1016/j.jgar.2022.10.007_bib0011 article-title: High prevalence of erythromycin-resistant Bordetella pertussis in Xi’an, China publication-title: Clin Microbiol Infect doi: 10.1111/1469-0691.12671 – volume: 35 start-page: 24 year: 2015 ident: 10.1016/j.jgar.2022.10.007_bib0016 article-title: Molecular epidemiology of Bordetella pertussis in the Philippines in 2012–2014 publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2015.04.001 – volume: 19 start-page: 1093 year: 2020 ident: 10.1016/j.jgar.2022.10.007_bib0014 article-title: The epidemic of erythromycin-resistant Bordetella pertussis with limited genome variation associated with pertussis resurgence in China publication-title: Expert Rev Vaccines doi: 10.1080/14760584.2020.1831916 – volume: 26 start-page: 2511 year: 2020 ident: 10.1016/j.jgar.2022.10.007_bib0008 article-title: Macrolide-resistant Bordetella pertussis, Vietnam, 2016 to 2017 publication-title: Emerg Infect Dis doi: 10.3201/eid2610.201035 – volume: 38 start-page: 370 year: 2019 ident: 10.1016/j.jgar.2022.10.007_bib0006 article-title: Bordetella pertussis infection in infants and young children in Shanghai, China, 2016–2017: Clinical features, genotype variations of antigenic genes and macrolides resistance publication-title: Pediatr Infect Dis J doi: 10.1097/INF.0000000000002160 – volume: 57 start-page: 1577 year: 2008 ident: 10.1016/j.jgar.2022.10.007_bib0025 article-title: Antimicrobial susceptibility testing of Bordetella pertussis in Taiwan prompted by a case of pertussis in a paediatric patient publication-title: J Med Microbiol doi: 10.1099/jmm.0.2008/002857-0 – volume: 23 start-page: 699 year: 2017 ident: 10.1016/j.jgar.2022.10.007_bib0020 article-title: Significant decrease in pertactin-deficient Bordetella pertussis isolates, Japan publication-title: Emerg Infect Dis doi: 10.3201/eid2304.161575 – volume: 9 year: 2014 ident: 10.1016/j.jgar.2022.10.007_bib0022 article-title: Solving the problem of comparing whole bacterial genomes across different sequencing platforms publication-title: PLoS One doi: 10.1371/journal.pone.0104984 – volume: 135 start-page: 331 year: 2015 ident: 10.1016/j.jgar.2022.10.007_bib0002 article-title: Duration of pertussis immunity after DTaP immunization: a meta-analysis publication-title: Pediatrics doi: 10.1542/peds.2014-1729 – volume: 10 year: 2015 ident: 10.1016/j.jgar.2022.10.007_bib0005 article-title: Variation in Bordetella pertussis susceptibility to erythromycin and virulence-related genotype changes in China (1970–2014) publication-title: PLoS One |
SSID | ssib050733640 ssj0000941267 |
Score | 2.3099473 |
Snippet | •Molecular surveillance of macrolide-resistant Bordetella pertussis (MRBP) was performed in East and Southeast Asia.•MBRP was detected in Vietnam, Cambodia,... Highlights•Molecular surveillance of macrolide-resistant B. pertussis (MRBP) was performed in East and South-East Asia. •MRBP was detected in Vietnam,... Macrolide-resistant Bordetella pertussis (MRBP) has been emerging and prevailing in mainland China since 2011. In this study, we aimed to investigate the... Objectives: Macrolide-resistant Bordetella pertussis (MRBP) has been emerging and prevailing in mainland China since 2011. In this study, we aimed to... |
SourceID | doaj proquest pubmed crossref elsevier |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 263 |
SubjectTerms | 23S rRNA Anti-Bacterial Agents - pharmacology Asia, Eastern Asia, Southeastern Bordetella pertussis Bordetella pertussis - genetics Drug Resistance, Bacterial East and Southeast Asia Genotype Humans Infectious Disease Macrolide-resistant A2047G mutation Macrolides - pharmacology Multilocus variable-number tandem-repeat analysis Mutation Whole-genome sequencing Whooping Cough - epidemiology |
Title | Genotyping and macrolide-resistant mutation of Bordetella pertussis in East and South-East Asia |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2213716522002387 https://www.clinicalkey.es/playcontent/1-s2.0-S2213716522002387 https://www.ncbi.nlm.nih.gov/pubmed/36270447 https://www.proquest.com/docview/2727641791 https://doaj.org/article/6eeb5630b1064b9fb7d9294a1f64738b |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQCArLS0bihgyJ7cTeY4u2rZDaC1TqzfJjLG1Fs1WTPXDhtzPjJKtWouXCJVKiOIlnxp7vU-bB2MccA8LkJEVssxI6SSVCjI2wyUp0SLYKS0oUPj1rT871t4vm4larL4oJG8sDj4L70gIEqmEVkLvosMzBJPTo2te51UbZQLsv-rxbZAotqaFWhG3JhpSyVgJJQTNlzIzBXZdU4hV5v_xcQrvMHa9UivffcU73gc_ihI6esicTeuQH41c_Y4-ge87cMXSb4RclPnHfJX7lI7XiSSCQShM87AZ-tR1_ufNN5odUbpOSRzy_hpthi3Pp-brjK98P5QGlrZ4opwf92r9g50erH19PxNQ3QUQE_4OAqs5g6wr0EhpTae1jC8YjOcDTZL1pwSqV1RL5KaIfFXNCGIfEzacKbNJqn-11mw5eMW4NbpYGUVnwDRKVZJugZE6kwWS1twtWz3JzcSoqTr0tfro5euzSkawdyZquoawX7NNuzPVYUuPBuw9JHbs7qRx2uYBG4iYjcf8ykgVTszLdnHGKeyQ-aP3gq83fRkE_LfPe1a6XrnLfycjIxqQsGAhHfpgtxuFypX8wvoPNtncS8WJLXd_qBXs5mtJuaqgM0pZ5_T-m_IY9pqmMkTdv2d5ws4V3iJ-G8L4sFTye_l79Ad_2FTQ |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genotyping+and+macrolide-resistant+mutation+of+Bordetella+pertussis+in+East+and+South-East+Asia&rft.jtitle=Journal+of+global+antimicrobial+resistance.&rft.au=Koide%2C+Kentaro&rft.au=Yao%2C+ShuMan&rft.au=Chiang%2C+Chuen-Sheue&rft.au=Thuy%2C+Phung+Thi+Bich&rft.date=2022-12-01&rft.issn=2213-7173&rft.eissn=2213-7173&rft.volume=31&rft.spage=263&rft_id=info:doi/10.1016%2Fj.jgar.2022.10.007&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2213-7165&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2213-7165&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2213-7165&client=summon |